Medications for Transfusion Dependent Thalassaemia Beta

1 result
  • casgevy

    (Exagamglogene Autotemcel)
    Vertex Pharmaceuticals Incorporated
    Casgevy is indicated for patients aged 12 and older with sickle cell disease (SCD) with recurrent vaso-occlusive crises, or transfusion-dependent β-thalassemia (TDT).